AstraZeneca wins appeal on Prilosec patents
The US Court of Appeals for the Federal Circuit has upheld the ruling of a District Court in favour of AstraZeneca in a patent infringement case against Apotex Corp and Impax Laboratories over its heartburn drug Prilosec
On August 20, the three-judge panel affirmed the May 2007 decision of US District Court Judge Barbara S Jones and ruled that Apotex and Impax had infringed two of AstraZeneca's patents (4,786,505 and 4,853,230).
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.